2020-07-28 11:39:56

A Vaccine by November? Science Journalist in Vaccine Trial Casts Doubt on Rosy U.S. Projections

With 30,000 people taking part in the first major COVID-19 vaccine study in the United States, hopes are high that the collaboration between drugmaker Moderna and the National Institutes of Health will yield positive results as early as November. Researchers around the world are working on more than 165 vaccine candidates, though only a handful are conducting large-scale human trials. DN! speaks with BBC science journalist Richard Fisher, who took part in the vaccine trial run by Oxford University that is among the most promising. "It was both a personal decision and a journalistic one," Fisher says of his decision to volunteer. "I wanted to do something that helps the collective effort to get us closer to a vaccine."

Democracy Now! produces a daily, global, independent news hour hosted by award-winning journalists Amy Goodman and Juan González.

Our reporting includes breaking daily news headlines and in-depth interviews with people on the front lines of the world’s most pressing issues.

On DN!, you’ll hear a diversity of voices speaking for themselves, providing a unique and sometimes provocative perspective on global events.

Missed an episode?  Check out DN on FSTV VOD anytime or visit the show page for the latest clips.

#FreeSpeechTV is one of the last standing national, independent news networks committed to advancing progressive social change.

#FSTV is available on Dish, DirectTV, AppleTV, Roku, Sling, and online at freespeech.org.

BBC Coronavirus COVID-19 Democracy Now! Journalist Moderna National Institutes of Health Oxford University Richard Fisher Science Vaccine

Related

Democracy Now!

Inequality Virus: Pandemic Widens Wealth Gap for Women, People of Color as Billionaire Profits Soar

Inequality Virus: Pandemic Widens Wealth Gap for Women, People of Color as Billionaire Profits Soar

Democracy Now!

Biden Is Reversing Trump’s Anti-Immigrant Acts. Will He Repair Harm from Deportations Under Obama?

Biden Is Reversing Trump’s Anti-Immigrant Acts. Will He Repair Harm from Deportations Under Obama?

Democracy Now!

Joe Biden Reverses Trump’s Trans Military Ban, But Assault on Rights Continues at State Level

Joe Biden Reverses Trump’s Trans Military Ban, But Assault on Rights Continues at State Level

The David Pakman Show

69% Approve of Biden's Week 1 COVID Response

69% Approve of Biden's Week 1 COVID Response